Efficacy of nitrosourea-based chemotherapy in recurrent malignant glioma according to time to adjuvant temozolomide failure: A pooled analysis.

Abstract

2060 Background: Concomitant and adjuvant temozolomide (TMZ) is the standard of care of the first-line treatment in glioblastoma (GBM) patients. At recurrence patients have few therapeutic options and the use of nitrosoureas, alternative schedule of TMZ and new target therapy have been widely studied. Recently Perry and colleagues (JCO 2010;28:2051-2057… (More)

Topics

Cite this paper

@article{Paccapelo2011EfficacyON, title={Efficacy of nitrosourea-based chemotherapy in recurrent malignant glioma according to time to adjuvant temozolomide failure: A pooled analysis.}, author={Alessandro Paccapelo and Ivan R. Lolli and Silvia Scoccianti and Beatrice Detti and Giovanni Silvano and Maria Grazia Fabrini and Francesco Perrone and Giuseppina Savio and Stefano Cascinu}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2011}, volume={29 15_suppl}, pages={2060} }